Two New Classes of 1-Type Calcium Channel Inhibitors with New Chemical Scaffolds from Ganoderma cochlear
Zhou, Feng-Jiao; Nian, Yin; Yan, Yongming; Gong, Ye; Luo, Qj; Zhang, Yu; Hou, Bo; Zuo, Zhi-Li; Wang, Shu-Mei; Jiang, He-Hai; Yang, Jian; Cheng, Yong-Xian
2015-06-19
发表期刊ORGANIC LETTERS
卷号17期号:12页码:3082-3085
摘要T-type calcium channel (TTCC) inhibitors hold great potential for the treatment of a variety of neurological disorders. Cochlearoids A-E (1-5), five pairs of dimeric meroterpenoid enantiomers, and cochlearines A (6) and B (7), two pairs of enantiomeric hybrid metabolites, were isolated and characterized from Ganoderma cochlear. Biological evaluation found that compounds (+)-1, (-)-3, and (+/-)-6 significantly inhibited Ca(v)3.1 TTCC and showed noticeable selectivity against Ca(v)1.2, Ca(v)2.1, Ca(v)2.2, and K(v)11.1 (hERG) channels.
DOI10.1021/acs.orglett.5b01353
收录类别SCI
语种英语
WOS记录号WOS:000356845000056
引用统计
文献类型期刊论文
条目标识符http://ir.kib.ac.cn/handle/151853/24965
专题植物化学与西部植物资源持续利用国家重点实验室
推荐引用方式
GB/T 7714
Zhou, Feng-Jiao,Nian, Yin,Yan, Yongming,et al. Two New Classes of 1-Type Calcium Channel Inhibitors with New Chemical Scaffolds from Ganoderma cochlear[J]. ORGANIC LETTERS,2015,17(12):3082-3085.
APA Zhou, Feng-Jiao.,Nian, Yin.,Yan, Yongming.,Gong, Ye.,Luo, Qj.,...&Cheng, Yong-Xian.(2015).Two New Classes of 1-Type Calcium Channel Inhibitors with New Chemical Scaffolds from Ganoderma cochlear.ORGANIC LETTERS,17(12),3082-3085.
MLA Zhou, Feng-Jiao,et al."Two New Classes of 1-Type Calcium Channel Inhibitors with New Chemical Scaffolds from Ganoderma cochlear".ORGANIC LETTERS 17.12(2015):3082-3085.
条目包含的文件 下载所有文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
2015625171447469.pdf(619KB)期刊论文作者接受稿开放获取CC BY-NC-SA浏览 下载
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhou, Feng-Jiao]的文章
[Nian, Yin]的文章
[Yan, Yongming]的文章
百度学术
百度学术中相似的文章
[Zhou, Feng-Jiao]的文章
[Nian, Yin]的文章
[Yan, Yongming]的文章
必应学术
必应学术中相似的文章
[Zhou, Feng-Jiao]的文章
[Nian, Yin]的文章
[Yan, Yongming]的文章
相关权益政策
暂无数据
收藏/分享
文件名: 2015625171447469.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。